Lihua Zhang

Title: Lihua Zhang: Innovator in Biological Pharmacy

Introduction

Lihua Zhang is a prominent inventor based in Tianjin, China, known for his contributions to the field of biological pharmacy. With a focus on developing innovative solutions for medical treatments, he has secured two patents that highlight his expertise and dedication to advancing healthcare.

Latest Patents

Zhang's latest patents include the "HM-3 fusion protein and application thereof," which pertains to a long-acting HM-3 fusion protein molecule. This invention addresses the challenges of druggability associated with small peptides by linking an active polypeptide HM-3 to a human Fc (IgG) fragment. The resulting fusion protein effectively prolongs the half-life of HM-3 and presents a potential treatment for autoimmune diseases, neovascular diseases, and osteoarthritis. Another significant patent is related to the "application of andrographolide in the preparation of a pharmaceutical for treatment of inflammatory bowel disease." This invention involves an andrographolide enteric targeting micropellet and its method of preparation, showcasing the therapeutic potential of andrographolide in treating inflammatory bowel disease.

Career Highlights

Throughout his career, Lihua Zhang has worked with notable companies such as Tasly Biopharmaceuticals Co., Ltd. and Tasly Pharmaceutical Group Co., Ltd. His work in these organizations has allowed him to contribute significantly to the development of innovative pharmaceutical solutions.

Collaborations

Zhang has collaborated with several professionals in his field, including Xiaohui Ma and Ruijing Huang, who have supported his research and development efforts.

Conclusion

Lihua Zhang's innovative work in biological pharmacy, particularly through his patents, demonstrates his commitment to improving medical treatments. His contributions have the potential to make a significant impact on healthcare and patient outcomes.